Impact of tumor response on improvement of quality of life in anemic cancer chemotherapy patients receiving Epoetin alfa.

被引：0

作者：

Bukowski, R ^{[1
]}

机构：

[1] CLEVELAND CLIN FDN,CLEVELAND,OH 44195

来源：

BLOOD | 1996年 / 88卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3282 / 3282

页数：1

共 50 条

[1] Effect of Epoetin alfa (procrit(R)) on quality of life (QOL) in anemic cancer patients receiving chemotherapy and early prediction of response to Epoetin alfa.
Demetri, G
Nemunaitis, J
Wade, J
[J]. BLOOD, 1996, 88 (10) : 3284 - 3284
[2] Marginal analysis to identify optimal hemoglobin levels to maximize quality of life improvement in anemic cancer patients receiving epoetin alfa.
Nortier, JWR
Zagari, M
Chen, Y
[J]. ANNALS OF ONCOLOGY, 2000, 11 : 145 - 146
[3] Epoetin alfa increases hemoglobin levels and improves quality of life in anemic geriatric cancer patients receiving chemotherapy
Matti S. Aapro
David C. Dale
Michael Blasi
Brenda Sarokhan
Fawzia Ahmed
Richard C. Woodman
[J]. Supportive Care in Cancer, 2006, 14 : 1184 - 1194
[4] Epoetin alfa increases hemoglobin levels and improves quality of life in anemic geriatric cancer patients receiving chemotherapy
Aapro, Matti S.
Dale, David C.
Blasi, Michael
Sarokhan, Brenda
Ahmed, Fawzia
Woodman, Richard C.
[J]. SUPPORTIVE CARE IN CANCER, 2006, 14 (12) : 1184 - 1194
[5] Influence of hemoglobin response to epoetin alfa on quality-of-life in anemic children with cancer receiving myelosuppressive chemotherapy.
Razzouk, BI
Hockenberry, M
Hinds, PS
Feusner, J
Rackoff, W
Hord, JD
[J]. BLOOD, 2004, 104 (11) : 609A - 610A
[6] Hematologic response to epoetin alfa correlates significantly with improved quality of life (QOL) in anemic cancer patients receiving myelotoxic chemotherapy (CT)
Harousseau, Jean-Luc
Lange, Winand
Thomas, Hilary
[J]. ANNALS OF ONCOLOGY, 2004, 15 : 220 - 220
[7] The effect of epoetin alfa on quality of life in anemic cancer patients
Cella, D
Bron, D
[J]. CANCER PRACTICE, 1999, 7 (04) : 177 - 182
[8] Epoetin alfa improves hemoglobin and quality of life in anemic geriatric cancer patients ≥60 years receiving chemotherapy.
Demetri, GD
Dale, DC
Aapro, MS
Woodman, RC
[J]. BLOOD, 2003, 102 (11) : 164B - 165B
[9] BENEFITS OF EPOETIN ALFA THERAPY IN ANEMIC CANCER-PATIENTS RECEIVING CHEMOTHERAPY
HENRY, DH
ABELS, R
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (09) : 2473 - 2474
[10] Regarding "randomized comparison of epoetin alfa and darbepoetin alfa in anemic patients with cancer receiving chemotherapy"
Nowrousian, Mohammad Resa
[J]. ONCOLOGIST, 2006, 11 (05): : 535 - 536

← 1 2 3 4 5 →